![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Vol. 29, Issue 9, 1176-1182, September 2001
Osaka Prefectural Institute of Public Health, Higashinari-ku,
Osaka, Japan (T.S., Y.O., K.I.); Department of Physiology and
Pharmacology, The University of Queensland, St. Lucia, Queensland,
Australia (E.M.J.G.); and Department of Biochemistry and Center in
Molecular Toxicology, Vanderbilt University School of Medicine,
Nashville, Tennessee (F.P.G.)
A variety of polycyclic aromatic hydrocarbons and their
dihydrodiol derivatives, arylamines, heterocyclic amines, and
nitroarenes, were incubated with cDNA-based recombinant
(Escherichia coli or Trichoplusia
ni) systems expressing different forms of human
cytochrome P450 (P450 or CYP) and NADPH-P450 reductase using
Salmonella typhimurium tester strain NM2009, and the
resultant DNA damage caused by the reactive metabolites was detected by
measuring expression of umu gene in the cells.
Recombinant (bacterial) CYP1A1 was slightly more active than any of
four CYP1B1 allelic variants, CYP1B1*1, CYP1B1*2, CYP1B1*3, and
CYP1B1*6, in catalyzing activation of chrysene-1,2-diol,
benz[a]anthracene-trans-1,2-, 3,4-, 5,6-, and 8,9-diol, fluoranthene-2,3-diol,
dibenzo[a,l]pyrene,
benzo[c]phenanthrene, and
dibenz[a,h]anthracene and several
arylamines and heterocyclic amines, whereas CYP1A1 and CYP1B1 enzymes
had essentially similar catalytic specificities toward other
procarcinogens, such as (+)-, (
)-, and
(±)-benzo[a]pyrene-7,8-diol,
5-methylchrysene-1,2-diol, 7,12-dimethylbenz[a]anthracene-3,4-diol,
dibenzo[a,l]pyrene-11,12-diol, benzo[b]fluoranthene-9,10-diol,
benzo[c]chrysene, 5,6-dimethylchrysene-1,2-diol, benzo[c]phenanthrene-3,4-diol,
7,12-dimethylbenz[a]anthracene, benzo[a]pyrene, 5-methylchrysene, and
benz[a]anthracene. We also determined activation of
these procarcinogens by recombinant (T. ni) human P450 enzymes in S.
typhimurium NM2009. There were good correlations between
activities of procarcinogen activation by CYP1A1 preparations expressed
in E. coli and T.
ni cells, although basal activities with three lots of
CYP1B1 in T. ni cells were very high
without substrates and NADPH in our assay system. Using 14 forms of
human P450s (but not CYP1B1) (in T. ni
cells), we found that CYP1A2, 2C9, 3A4, and 2C19 catalyzed activation
of several of polycyclic aromatic hydrocarbons at much slower rates than those catalyzed by CYP1A1 and that other enzymes, including CYP2A6, 2B6, 2C8, 2C18, 2D6, 2E1, 3A5, 3A7, and 4A11, were almost inactive in the activation of polycyclic aromatic hydrocarbons examined here.
This article has been cited by other articles:
|
|
 |
|
  J.-H. Park, D. Mangal, A. J. Frey, R. G. Harvey, I. A. Blair, and T. M. Penning Aryl Hydrocarbon Receptor Facilitates DNA Strand Breaks and 8-Oxo-2'-deoxyguanosine Formation by the Aldo-Keto Reductase Product Benzo[a]pyrene-7,8-dione J. Biol. Chem., October 23, 2009; 284(43): 29725 - 29734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. D. Kekatpure, A. J. Dannenberg, and K. Subbaramaiah HDAC6 Modulates Hsp90 Chaperone Activity and Regulates Activation of Aryl Hydrocarbon Receptor Signaling J. Biol. Chem., March 20, 2009; 284(12): 7436 - 7445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Johansson, U. Jurva, G. Gronberg, L. Weidolf, and C. Masimirembwa Novel Metabolites of Amodiaquine Formed by CYP1A1 and CYP1B1: Structure Elucidation Using Electrochemistry, Mass Spectrometry, and NMR Drug Metab. Dispos., March 1, 2009; 37(3): 571 - 579. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Castro, Z. Yu, C. V. Lohr, C. B. Pereira, J. N. Giovanini, K. A. Fischer, G. A. Orner, R. H. Dashwood, and D. E. Williams Chemoprevention of dibenzo[a,l]pyrene transplacental carcinogenesis in mice born to mothers administered green tea: primary role of caffeine Carcinogenesis, August 1, 2008; 29(8): 1581 - 1586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Castro, W. M. Baird, C. B. Pereira, J. Giovanini, C. V. Lohr, K. A. Fischer, Z. Yu, F. J. Gonzalez, S. K. Krueger, and D. E. Williams Fetal Mouse Cyp1b1 and Transplacental Carcinogenesis from Maternal Exposure to Dibenzo(a,l)pyrene Cancer Prevention Research, July 1, 2008; 1(2): 128 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Kondraganti, W. Jiang, A. K. Jaiswal, and B. Moorthy Persistent Induction of Hepatic and Pulmonary Phase II Enzymes by 3-Methylcholanthrene in Rats Toxicol. Sci., April 1, 2008; 102(2): 337 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. G. Shertzer, M. B. Genter, G. Talaska, C. P. Curran, D. W. Nebert, and T. P. Dalton 7H-dibenzo[c,g]carbazole metabolism by the mouse and human CYP1 family of enzymes Carcinogenesis, June 1, 2007; 28(6): 1371 - 1378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Rajapaksa, I. G. Sipes, and P. B. Hoyer Involvement of Microsomal Epoxide Hydrolase Enzyme in Ovotoxicity Caused by 7,12-Dimethylbenz[a]anthracene Toxicol. Sci., April 1, 2007; 96(2): 327 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Paracchini, S. Raimondi, I. T. Gram, D. Kang, N. A. Kocabas, V. N. Kristensen, D. Li, F. F. Parl, T. Rylander-Rudqvist, P. Soucek, et al. Meta- and Pooled Analyses of the Cytochrome P-450 1B1 Val432Leu Polymorphism and Breast Cancer: A HuGE-GSEC Review Am. J. Epidemiol., January 15, 2007; 165(2): 115 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-L. Wu, C. D. Sohl, T. Shimada, and F. P. Guengerich Recombinant Enzymes Overexpressed in Bacteria Show Broad Catalytic Specificity of Human Cytochrome P450 2W1 and Limited Activity of Human Cytochrome P450 2S1 Mol. Pharmacol., June 1, 2006; 69(6): 2007 - 2014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Uno, T. P. Dalton, N. Dragin, C. P. Curran, S. Derkenne, M. L. Miller, H. G. Shertzer, F. J. Gonzalez, and D. W. Nebert Oral Benzo[a]pyrene in Cyp1 Knockout Mouse Lines: CYP1A1 Important in Detoxication, CYP1B1 Metabolism Required for Immune Damage Independent of Total-Body Burden and Clearance Rate Mol. Pharmacol., April 1, 2006; 69(4): 1103 - 1114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Sissung, D. K. Price, A. Sparreboom, and W. D. Figg Pharmacogenetics and Regulation of Human Cytochrome P450 1B1: Implications in Hormone-Mediated Tumor Metabolism and a Novel Target for Therapeutic Intervention Mol. Cancer Res., March 1, 2006; 4(3): 135 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Yu, C. V. Loehr, K. A. Fischer, M. A. Louderback, S. K. Krueger, R. H. Dashwood, N. I. Kerkvliet, C. B. Pereira, J. E. Jennings-Gee, S. T. Dance, et al. In utero Exposure of Mice to Dibenzo[a,l]Pyrene Produces Lymphoma in the Offspring: Role of the Aryl Hydrocarbon Receptor Cancer Res., January 15, 2006; 66(2): 755 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Uno, T. P. Dalton, S. Derkenne, C. P. Curran, M. L. Miller, H. G. Shertzer, and D. W. Nebert Oral Exposure to Benzo[a]pyrene in the Mouse: Detoxication by Inducible Cytochrome P450 Is More Important Than Metabolic Activation Mol. Pharmacol., May 1, 2004; 65(5): 1225 - 1237. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Li, H. Chen, M.-S. Tang, X. Shi, S. Amin, D. Desai, M. Costa, and C. Huang PI-3K and Akt are mediators of AP-1 induction by 5-MCDE in mouse epidermal Cl41 cells J. Cell Biol., April 12, 2004; 165(1): 77 - 86. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Schwarz, P. Kisselev, and I. Roots St. John's Wort Extracts and Some of Their Constituents Potently Inhibit Ultimate Carcinogen Formation from Benzo[a]pyrene-7,8-Dihydrodiol by Human CYP1A1 Cancer Res., November 15, 2003; 63(22): 8062 - 8068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Rylander-Rudqvist, S. Wedren, F. Granath, K. Humphreys, S. Ahlberg, E. Weiderpass, M. Oscarson, M. Ingelman-Sundberg, and I. Persson Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk Carcinogenesis, September 1, 2003; 24(9): 1533 - 1539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Gibson, J. H. Gill, P. A. Khan, J. M. Seargent, S. W. Martin, P. A. Batman, J. Griffith, C. Bradley, J. A. Double, M. C. Bibby, et al. Cytochrome P450 1B1 (CYP1B1) Is Overexpressed in Human Colon Adenocarcinomas Relative to Normal Colon: Implications for Drug Development Mol. Cancer Ther., June 1, 2003; 2(6): 527 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yang, J.-Y. Jang, S. Kim, S.-M. Lee, S.-S. Chang, H.-K. Cheong, E. Lee, D. Kang, H. Kim, T. Kawamoto, et al. Genetic effects on urinary 1-hydroxypyrene levels in a Korean population Carcinogenesis, June 1, 2003; 24(6): 1085 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chen, N. Nguyen, K. Tamura, M. Karin, and R. H. Tukey The Role of the Ah Receptor and p38 in Benzo[a]pyrene-7,8-dihydrodiol and Benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide-induced Apoptosis J. Biol. Chem., May 23, 2003; 278(21): 19526 - 19533. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ramos-Gomez, P. M. Dolan, K. Itoh, M. Yamamoto, and T. W. Kensler Interactive effects of nrf2 genotype and oltipraz on benzo[a]pyrene-DNA adducts and tumor yield in mice Carcinogenesis, March 1, 2003; 24(3): 461 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. E. Caporaso Why Have We Failed to Find the Low Penetrance Genetic Constituents of Common Cancers? Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1544 - 1549. [Full Text] [PDF]
|
|
|
|
|
|
T. Shimada, K. Inoue, Y. Suzuki, T. Kawai, E. Azuma, T. Nakajima, M. Shindo, K. Kurose, A. Sugie, Y. Yamagishi, et al. Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice Carcinogenesis, July 1, 2002; 23(7): 1199 - 1207. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
